# PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO)

> **NCT03391232** · PHASE1,PHASE2 · COMPLETED · sponsor: **Treos Bio Zrt** · enrollment: 11 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** PolyPEPI1018 CRC Vaccine

## Key facts

- **NCT ID:** NCT03391232
- **Lead sponsor:** Treos Bio Zrt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-03
- **Primary completion:** 2019-07-17
- **Final completion:** 2019-07-17
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-05-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391232, "PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03391232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*